Long-term debt · 2024–2025

Medline long-term debt

$12.5B−24.0% · FY2025

Medline (MDLN) reported $12.5B in long-term debt for fiscal 2025, −24.0% year on year.

$16.4B2024$12.5B2025
Medline — Long-term debt, 2024–2025
Fiscal yearLong-term debtChangeFiling
FY20252025-12-31$12.5B−24.0%Open →
FY20242024-12-31$16.4B—Open →

Long-term debt — Long-term debt is borrowing due more than a year out. A large figure is normal for capital-intensive businesses and says nothing on its own about financial health.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2024–2025 compound annual growth −24.0%

Long-term debt at companies of similar size

Full ranking by long-term debt →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Medline long-term debt |url=https://companiesranked.com/en/company/medline/long-term-debt |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Medline long-term debt. CompaniesRanked. https://companiesranked.com/en/company/medline/long-term-debt

BibTeX

@misc{companiesranked-en-company-medline-long-term-debt-2026,
  author       = {{CompaniesRanked}},
  title        = {{Medline long-term debt}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/medline/long-term-debt}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0002046386-26-000051 · August 5, 2026

{{cite web |title=Medline long-term debt — 10-Q (0002046386-26-000051) |url=https://www.sec.gov/Archives/edgar/data/2046386/000204638626000051/mdln-20260627.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Medline overview